Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
Date:8/1/2013

other drugs targeting the sphingosine 1-phosphate subtype 1 (S1P1) receptor. Further evaluation of the data is ongoing.

Second Quarter 2013 Financial Results

  • Revenues totaled $68.9 million, including $1.3 million in net product sales and $65.5 million in milestone payments.
  • Research and development expenses totaled $18.8 million.
  • General and administrative expenses totaled $8.6 million.
  • Net income allocable to common stockholders was $40.1 million, or $0.18 per share.
  • At June 30, 2013, cash and cash equivalents totaled $178.9 million and approximately 218.2 million shares of common stock were outstanding.
  • Scheduled Conference Call and WebcastArena will host a conference call and webcast to provide a corporate update and report second quarter 2013 financial results today at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Second Quarter 2013 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

    Upcoming Conference ParticipationArena is planning to participate at upcoming investment and industry conferences, including:

  • Bank of America Merrill Lynch Global Healthcare Conference, September 11-13, 2013, London, England
  • 49th Annual Meeting of the European Association for the Study of Diabetes, September 23-27, 2013, Barcelona, Spain
  • NewsMakers in the Biotech Industry, September 27, 2013, New York, New Y
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
    2. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
    3. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
    4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
    5. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
    6. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
    7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
    8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
    9. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
    10. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
    11. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( ... "Dental Consumables Market - Global Industry Analysis, Size, Share, ... to their offering. (Logo: ... which are used on patients in order to treat ...
    (Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
    (Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
    Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2
    ... Remission / Unconfirmed Complete Remission Rate 3.5 Fold Higher ... Compared to Standard ... and MTA: CTIC) announced today that it achieved the primary,efficacy ... for patients with advanced, relapsed aggressive non-Hodgkin,s,lymphoma (NHL) based on ...
    ... PRINCETON, N.J., Nov. 10 Pharmasset, Inc.,(Nasdaq: VRUS ... ITMN ) today,announced that the first patients have been ... with the hepatitis C virus (HCV).,The trial (run in ... to,investigate the combination of two oral antiviral molecules in ...
    Cached Medicine Technology:Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 2Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 3Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 2Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 3Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 5
    (Date:4/23/2014)... 2014) The American Gastroenterological Association (AGA) Research ... Research Scholars. The AGA Research Scholar Awards program, ... independent and productive research careers in digestive diseases. ... an additional year allowing for three consecutive years ... junior faculty who are paving the way for ...
    (Date:4/23/2014)... a country as wealthy as the United States, it may ... not have access to adequate food due to lack of ... , Recent research at the University of Illinois using data ... that the seniors who are dealing with hunger are also ... 8.35 percent of Americans over age 60 faced the threat ...
    (Date:4/23/2014)... and physicians concerned about an increase in adolescents, marijuana ... a sigh of relief. According to a new study ... of data from states with and without medical marijuana ... use among adolescents. The study is published online in ... Health . , "Any time a state considers ...
    (Date:4/23/2014)... the depletion of self-control, according to research published in ... for Psychological Science. , Self-control can be difficult ... on a boring textbook are hard things to do. ... Exerting self-control for a long period seems to "deplete" ... , "It is as if self-control is a limited ...
    (Date:4/22/2014)... high school sport in the United States with 1 ... in the Center for Injury Research and Policy at ... describe the occurrence and distribution patterns of basketball-related injuries ... training setting among adolescents and teens. , The study, ... , examined data relating to adolescents 13-19 years of ...
    Breaking Medicine News(10 mins):Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:More Americans in their golden years are going hungry 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:ADHD drug may help preserve our self-control resources 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3
    ... , ... Health GPS uses the latest technology to help women locate the closest medical ... was developed by the Breast Health & Healing Foundation, (BHH&F) www.breasthealthandhealing.com , a ... , ...
    ... (TSX Venture: DIV, OTC Bulletin Board: DVNTF) is increasing its focus on secure mobile healthcare, the company announced today at CTIA Wireless 2010. , ... , ... ... ...
    ... to better predict the effects of strokes and other ... for study of brain organization, neurologists at Washington University ... The technique, known as resting-state functional connectivity (FC), reveals ... of the brain collaborate. Previous studies have shown that ...
    ... ,CAMDEN Americans consume innumerable amounts of medicine, but only ... marks the 50th anniversary of oral contraception, an innovative collaboration ... the development of the 20th century. As ... comprehensive biography on Rock has its origins at Rutgers UniversityCamden. ...
    ... ago, findings suggest , TUESDAY, March 23 (HealthDay ... are the earliest direct evidence that our tree-dwelling ancestors ... fossil footprints preserved in volcanic ash were discovered in ... have debated whether the tracks indicate a modern human-like ...
    ... ... the survivors of the earthquake in Haiti. The Grand Canyon University community has donated more ... struck on January 12, 2010. , ... Phoenix, AZ (PRWEB) March 23, 2010 -- Grand Canyon University,s Compassion and ...
    Cached Medicine News:Health News:IPhone App is New Tool in the Fight Against Breast Cancer 2Health News:Diversinet Expands Mobile Healthcare Focus 2Health News:Diversinet Expands Mobile Healthcare Focus 3Health News:Diversinet Expands Mobile Healthcare Focus 4Health News:Diversinet Expands Mobile Healthcare Focus 5Health News:Diversinet Expands Mobile Healthcare Focus 6Health News:Diversinet Expands Mobile Healthcare Focus 7Health News:Diversinet Expands Mobile Healthcare Focus 8Health News:Diversinet Expands Mobile Healthcare Focus 9Health News:Diversinet Expands Mobile Healthcare Focus 10Health News:Scans of brain networks may help predict injury's effects 2Health News:Rutgers historian puts 50th anniversary of the pill into cultural medicine cabinet 2Health News:Rutgers historian puts 50th anniversary of the pill into cultural medicine cabinet 3Health News:Grand Canyon University (GCU) Creates Special Relief Fund and Raises Money for Haiti Earthquake Survivors 2
    ... Gore's EXCLUDER AAA Endoprosthesis is an ... invasive treatment option for patients with abdominal ... a durable ePTFE bifurcated graft with an ... both device flexibility and material durability. The ...
    ... remove a cast from an arm or leg ... are cut or burned by the cast saw ... to remove any cast with confidence. This innovative, ... and burns from the cast saw and can ...
    ... choice plays an important part in ... particularly where reduced capsule formation, inflammation ... considerations. GORE-TEX Suture, a nonabsorbable, ePTFE ... characteristics sought by a variety of ...
    ... Patch utilizes advanced fluoropolymer technology, ... penetrating suture and decrease suture ... as 88 percent. This improvement, ... multi-directional strength and low thrombogenicity, ...
    Medicine Products: